"Patient Selection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.
| Descriptor ID |
D018579
|
| MeSH Number(s) |
E05.581.500.653 N04.590.731
|
| Concept/Terms |
Patient Selection- Patient Selection
- Patient Selections
- Selection, Patient
- Selections, Patient
Research Subject Recruitment- Research Subject Recruitment
- Recruitment, Research Subject
- Recruitments, Research Subject
- Research Subject Recruitments
- Subject Recruitment, Research
- Subject Recruitments, Research
Research Subject Selection- Research Subject Selection
- Research Subject Selections
- Selection, Research Subject
- Selections, Research Subject
- Subject Selection, Research
- Subject Selections, Research
Selection for Treatment- Selection for Treatment
- Selection for Treatments
- Treatment, Selection for
- Treatments, Selection for
Patient Recruitment- Patient Recruitment
- Patient Recruitments
- Recruitment, Patient
- Recruitments, Patient
|
Below are MeSH descriptors whose meaning is more general than "Patient Selection".
Below are MeSH descriptors whose meaning is more specific than "Patient Selection".
This graph shows the total number of publications written about "Patient Selection" by people in this website by year, and whether "Patient Selection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 1 | 3 | 4 |
| 1997 | 1 | 9 | 10 |
| 1998 | 0 | 4 | 4 |
| 1999 | 2 | 7 | 9 |
| 2000 | 4 | 7 | 11 |
| 2001 | 2 | 8 | 10 |
| 2002 | 1 | 5 | 6 |
| 2003 | 2 | 9 | 11 |
| 2004 | 3 | 9 | 12 |
| 2005 | 4 | 6 | 10 |
| 2006 | 4 | 11 | 15 |
| 2007 | 6 | 20 | 26 |
| 2008 | 3 | 24 | 27 |
| 2009 | 8 | 15 | 23 |
| 2010 | 7 | 25 | 32 |
| 2011 | 5 | 39 | 44 |
| 2012 | 0 | 16 | 16 |
| 2013 | 7 | 27 | 34 |
| 2014 | 5 | 20 | 25 |
| 2015 | 4 | 17 | 21 |
| 2016 | 5 | 19 | 24 |
| 2017 | 5 | 18 | 23 |
| 2018 | 11 | 19 | 30 |
| 2019 | 6 | 27 | 33 |
| 2020 | 10 | 28 | 38 |
| 2021 | 7 | 6 | 13 |
| 2022 | 2 | 4 | 6 |
| 2023 | 1 | 4 | 5 |
| 2024 | 8 | 10 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patient Selection" by people in Profiles.
-
Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities. Ann Surg Oncol. 2025 Mar; 32(3):2038-2044.
-
Clinical trial screening in gynecologic oncology: Defining the need and identifying best practices. Gynecol Oncol. 2025 Jan; 192:111-119.
-
Artificial Intelligence-Driven Patient Selection for Preoperative Portal Vein Embolization for Patients with Colorectal Cancer Liver Metastases. J Vasc Interv Radiol. 2025 Mar; 36(3):477-488.
-
Beyond Tuskegee: A contemporary qualitative assessment of barriers to research participation among Black women. Cancer. 2025 Jan 01; 131(1):e35648.
-
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium. J Natl Cancer Inst. 2024 Nov 01; 116(11):1721-1729.
-
Tabular review of contemporary open surgical repair experiences for treatment of thoracoabdominal aortic aneurysms. J Cardiovasc Surg (Torino). 2024 Oct; 65(5):490-498.
-
Comparison of targeted web-based advertising versus traditional methods for recruiting older adults into clinical trials. J Am Geriatr Soc. 2025 Jan; 73(1):182-192.
-
Deep Brain Stimulation for Childhood Treatment-Resistant Obsessive-Compulsive Disorder: Mental Health Clinician Views on Candidacy Factors. AJOB Empir Bioeth. 2025 Jan-Mar; 16(1):32-41.
-
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL. Blood Adv. 2024 08 27; 8(16):4414-4422.
-
Bladder-sparing Therapy for Bacillus Calmette-Gu?rin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection. Eur Urol. 2024 Dec; 86(6):516-527.